Predicting (side) effects for patients with inflammatory bowel disease: The promise of pharmacogenetics

Inflammatory bowel disease (IBD) is a chronic and heterogeneous intestinal inflammatory disorder. The medical management of IBD aims for long-lasting disease remission to prevent complications and disease progression. Early introduction of immunosuppression forms the mainstay of medical IBD manageme...

Descripción completa

Detalles Bibliográficos
Autores principales: Voskuil, Michiel Dirk, Bangma, Amber, Weersma, Rinse Karel, Festen, Eleonora Anna Margaretha
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Baishideng Publishing Group Inc 2019
Materias:
Opinion Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6558438/
https://www.ncbi.nlm.nih.gov/pubmed/31210708
http://dx.doi.org/10.3748/wjg.v25.i21.2539

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6558438/
https://www.ncbi.nlm.nih.gov/pubmed/31210708
http://dx.doi.org/10.3748/wjg.v25.i21.2539

Ejemplares similares